NCM
GILD icon

Neumann Capital Management’s Gilead Sciences GILD Stock Holding History

Neumann Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.53M Sell
35,868
-200
-0.6% -$26.4K 3% 11
2026
Q1 		$5.03M Sell
36,068
-822
-2% -$115K 1.48% 14
2025
Q4 		$4.53M Sell
36,890
-100
-0.3% -$12.2K 1.31% 20
2025
Q3 		$4.11M Sell
36,990
-1,700
-4% -$193K 1.2% 22
2025
Q2 		$4.29M Sell
38,690
-800
-2% -$85.1K 1.35% 18
2025
Q1 		$4.42M Sell
39,490
-300
-0.8% -$31K 1.53% 17
2024
Q4 		$3.68M Hold
39,790
– – 1.22% 22
2024
Q3 		$3.34M Sell
39,790
-1,500
-4% -$114K 1.11% 22
2024
Q2 		$2.83M Buy
41,290
+300
+0.7% +$20K 0.97% 25
2024
Q1 		$3M Buy
40,990
+800
+2% +$61.5K 1.07% 25
2023
Q4 		$3.26M Hold
40,190
– – 1.29% 21
2023
Q3 		$3.01M Sell
40,190
-600
-1% -$46.1K 1.31% 18
2023
Q2 		$3.14M Sell
40,790
-760
-2% -$60.6K 1.3% 17
2023
Q1 		$3.45M Sell
41,550
-850
-2% -$70.4K 1.52% 16
2022
Q4 		$3.64M Sell
42,400
-400
-0.9% -$31.7K 1.71% 16
2022
Q3 		$2.64M Buy
42,800
+40
+0.1% +$2.52K 1.36% 22
2022
Q2 		$2.64M Hold
42,760
– – 1.34% 21
2022
Q1 		$2.54M Sell
42,760
-400
-0.9% -$25.6K 1.08% 27
2021
Q4 		$3.13M Hold
43,160
– – 1.28% 23
2021
Q3 		$3.02M Hold
43,160
– – 1.35% 21
2021
Q2 		$2.97M Hold
43,160
– – 1.33% 22
2021
Q1 		$2.79M Hold
43,160
– – 1.33% 21
2020
Q4 		$2.52M Hold
43,160
– – 1.27% 23
2020
Q3 		$2.73M Sell
43,160
-200
-0.5% -$13.9K 1.57% 17
2020
Q2 		$3.34M Sell
43,360
-600
-1% -$46K 2.04% 15
2020
Q1 		$3.29M Hold
43,960
– – 2.39% 13
2019
Q4 		$2.86M Sell
43,960
-1,400
-3% -$91.2K 1.66% 17
2019
Q3 		$2.88M Hold
45,360
– – 1.78% 15
2019
Q2 		$3.06M Sell
45,360
-1,000
-2% -$65.8K 1.9% 15
2019
Q1 		$3.01M Sell
46,360
-1,118
-2% -$74.3K 1.93% 15
2018
Q4 		$2.97M Sell
47,478
-3,082
-6% -$215K 2.24% 14
2018
Q3 		$3.9M Hold
50,560
– – 2.3% 16
2018
Q2 		$3.58M Sell
50,560
-470
-0.9% -$33.2K 2.25% 15
2018
Q1 		$3.85M Buy
51,030
+260
+0.5% +$20.7K 2.45% 14
2017
Q4 		$3.64M Sell
50,770
-6,704
-12% -$509K 2.23% 15
2017
Q3 		$4.66M Sell
57,474
-6,785
-11% -$519K 2.88% 12
2017
Q2 		$4.55M Sell
64,259
-2,920
-4% -$194K 2.93% 12
2017
Q1 		$4.56M Sell
67,179
-5,000
-7% -$352K 2.96% 11
2016
Q4 		$5.17M Buy
72,179
+254
+0.4% +$18.9K 3.33% 8
2016
Q3 		$5.69M Sell
71,925
-550
-0.8% -$44.7K 3.78% 7
2016
Q2 		$6.05M Sell
72,475
-406
-0.6% -$36K 4.01% 5
2016
Q1 		$6.7M Buy
72,881
+670
+0.9% +$60.4K 4.41% 4
2015
Q4 		$7.31M Sell
72,211
-1,150
-2% -$120K 5.08% 1
2015
Q3 		$7.2M Sell
73,361
-150
-0.2% -$16.7K 5.09% 1
2015
Q2 		$8.61M Sell
73,511
-540
-0.7% -$59K 5.5% 1
2015
Q1 		$7.27M Buy
74,051
+350
+0.5% +$35.5K 4.64% 1
2014
Q4 		$6.95M Buy
+73,701
New +$7.62M 4.53% 1

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM

Neumann Capital Management's GILD Position: Q2 2026 in Review

Neumann Capital Management reduced its Gilead Sciences (GILD) stake by 0.55% in Q2 2026, selling an estimated $26.4K and leaving 35,868 shares worth $4.53M. The position accounts for 3% of the portfolio, ranked #11.

Neumann Capital Management first reported a position in GILD in Q4 2014 and has held it in 47 quarters since. The position peaked at $8.61M in Q2 2015. 973 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Neumann Capital Management held 35,868 shares of Gilead Sciences worth $4.53M as of Q2 2026.
  • Neumann Capital Management sold 200 Gilead Sciences shares in Q2 2026, an estimated $26.4K.
  • Gilead Sciences made up 3% of Neumann Capital Management's portfolio in Q2 2026, its #11 holding.
  • Neumann Capital Management first reported a position in Gilead Sciences in Q4 2014 and has held it in 47 quarters since.
  • Neumann Capital Management's Gilead Sciences position peaked at $8.61M in Q2 2015.
  • 973 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Neumann Capital Management's 13F filing for Q2 2026, filed 13 Jul 2026.